PATENT CLAIM ANALYSIS

Application Number: 16242352
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "210130"]

Abstract:
The present disclosure relates to a pharmaceutical composition comprising: (a) β-lactam antibiotics and (b) a metallo-β-lactamases (MBLs) inhibitor. The inhibitor relates to Bi(III) compounds or the pharmaceutically acceptable salts thereof. The present patent also provides methods of making Bi(III) compounds or the pharmaceutically acceptable salts thereof. Also provided is a method for treating MBLs-producing bacterial infection using a metal replacement mechanism.

Claim (Index 34):
The composition of  claim 33  wherein the Bi(III) complex is a monomer, dimer or polymer.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 99.0
- Lexical Diversity: 1.625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15278916', '14888764', '14694550', '15463952', '15111576']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7374267874997106
- 35 USC 102 Novelty (BERT): 0.5511268563648345
- Combined Prediction Score: 0.7187967943862229
- Mean Citation Score: 275.518766
- Max Citation Score: 403.69467
- Similarity Product: 251.13999240898488

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test